Abstract
Background: Cerebral Small Vessel Disease (SVD) can cause cognitive impairment, disability and dementia. While it is still unclear about the pathogenesis of SVD, several risk factors of SVD have been identified, and studies suggested that hypertension may play a critical role in SVD. Furthermore, studies have demonstrated that CYP2J2 isoform, 50 G>T variant, is associated with increasing the risk of ischemic stroke. Thus, we hypothesized that CYP2J2 50 G>T variant is associated with increased risk of cerebral SVD.
Methods: Thus, in this case-control study, we evaluated the association of CYP2J2 polymorphisms with the susceptibility to cerebral SVD in a population of Chinese Han adults.
Results: We found that CYP2J2 50 G>T genotype was significantly higher in SVD patients compared to healthy control group. Furthermore, 50 G>T genotype of CYP2J2 was associated with a significantly higher risk of SVD. Additionally, this polymorphism was significantly associated with WMH volume and a number of impaired cognitive domains in SVD patients.
Conclusion: In conclusion, our study demonstrated that CYP2J2 50 G>T polymorphism is associated with increased risk of cerebral SVD in Han Chinese.
Keywords: CYP2J2, 50 G>T variant, polymorphism, cerebral small vessel disease, cognitive impairment, dementia.
Current Neurovascular Research
Title:Cerebral Small Vessel Disease is Associated with Genetic Variations in CYP2J
Volume: 14 Issue: 4
Author(s): Ming Yao, Daping Lv, Jiajia Huo and Zhongwu Sun*
Affiliation:
- The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui,China
Keywords: CYP2J2, 50 G>T variant, polymorphism, cerebral small vessel disease, cognitive impairment, dementia.
Abstract: Background: Cerebral Small Vessel Disease (SVD) can cause cognitive impairment, disability and dementia. While it is still unclear about the pathogenesis of SVD, several risk factors of SVD have been identified, and studies suggested that hypertension may play a critical role in SVD. Furthermore, studies have demonstrated that CYP2J2 isoform, 50 G>T variant, is associated with increasing the risk of ischemic stroke. Thus, we hypothesized that CYP2J2 50 G>T variant is associated with increased risk of cerebral SVD.
Methods: Thus, in this case-control study, we evaluated the association of CYP2J2 polymorphisms with the susceptibility to cerebral SVD in a population of Chinese Han adults.
Results: We found that CYP2J2 50 G>T genotype was significantly higher in SVD patients compared to healthy control group. Furthermore, 50 G>T genotype of CYP2J2 was associated with a significantly higher risk of SVD. Additionally, this polymorphism was significantly associated with WMH volume and a number of impaired cognitive domains in SVD patients.
Conclusion: In conclusion, our study demonstrated that CYP2J2 50 G>T polymorphism is associated with increased risk of cerebral SVD in Han Chinese.
Export Options
About this article
Cite this article as:
Yao Ming , Lv Daping , Huo Jiajia and Sun Zhongwu *, Cerebral Small Vessel Disease is Associated with Genetic Variations in CYP2J, Current Neurovascular Research 2017; 14 (4) . https://dx.doi.org/10.2174/1567202614666171017151128
DOI https://dx.doi.org/10.2174/1567202614666171017151128 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
subject Index To Volume 1
Current Drug Targets - Inflammation & Allergy On the Psychotropic Effects of Carbon Dioxide
Current Pharmaceutical Design Subject Index To Volume 1
Recent Patents on Cardiovascular Drug Discovery Acute Phase Proteins In Acute Coronary Syndrome: An up-to-date
Cardiovascular & Hematological Agents in Medicinal Chemistry Metabotropic Glutamate Receptors and Interacting Proteins: Evolving Drug Targets
Current Drug Targets Aptiom (Eslicarbazepine Acetate) as a Dual Inhibitor of β-Secretase and Voltage-Gated Sodium Channel: Advancement in Alzheimer's Disease-Epilepsy Linkage via an Enzoinformatics Study
CNS & Neurological Disorders - Drug Targets Crosstalk between Behavior and Immune System During the Prodromal Stages of Alzheimer`s Disease
Current Pharmaceutical Design Editorial [ Hot Topic: Anti Alzheimer Agents (Guest Editor: Helmut Hugel)]
Mini-Reviews in Medicinal Chemistry Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders
Current Medicinal Chemistry Multiple Roles for Chemokines in the Pathogenesis of SIV Infection
Current HIV Research An fMRI Stroop Task Study of Prefrontal Cortical Function in Normal Aging, Mild Cognitive Impairment, and Alzheimers Disease
Current Alzheimer Research Analysis of Copy Number Variation in Alzheimer’s Disease: The NIALOAD/ NCRAD Family Study
Current Alzheimer Research NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets The Role of Vascular Factors in Late-Onset Sporadic Alzheimers Disease. Genetic and Molecular Aspects
Current Alzheimer Research Smoking and Hypertension: Effects on Clinical, Biochemical and Pathological Variables Due to Isolated or Combined Action on Cardiovascular System
Current Pharmaceutical Design ADAM Proteases: Protective Role in Alzheimers and Prion Diseases ?
Current Alzheimer Research Heterogeneity in Cost-Effectiveness Analysis of Vaccination for Mild and Moderate Alzheimer’s Disease
Current Alzheimer Research Clinical Applications of Transcranial Doppler Sonography
Reviews on Recent Clinical Trials Cholinesterase Inhibitors and Beyond
Current Alzheimer Research The Many Faces of Amyloid β in Alzheimers Disease
Current Molecular Medicine